Pharma: Page 44
-
PharmaVoice Team/PharmaVoice
Real-Time Hope for Rare Diseases
With advances in genomics sequencing combined with AI and other tools to speed up data analysis, the potential for quickly diagnosing and ultimately developing therapies that can treat patients with rare diseases in real time grows. The rare diseases space has come on leaps and bounds over the pa...
By Kim Ribbink • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
The Changing Role of the Traditional Pharma Brand
Experts say the industry needs to reinvent its role to create value in diagnostics, prevention, and digital health solutions beyond its traditional brands. According to a Strategy& report out earlier this year, healthcare will be centered on patients who are empowered to prevent diseases rath...
By Robin Robinson • Nov. 19, 2019 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Imagine if… When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry 15 years ago it began a movement. We sought to capture that intangible measure of a person’s influence: inspiration. And we thought who better to identify these individuals than you, our readers...
By Taren Grom • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 Who's on the List - By Category
Who’s on the List — 2019 Indexed by Category Commanders & Chiefs Paul Balagot precisioneffect Percival Barretto-Ko Astellas US Udit Batra MilliporeSigma Dan Bradbury Equillium Dr. Pablo Cagnoni Rubius Therapeutics Sharon Callahan TBWA\WorldHealth Dr. Donald Deieso WIRB-Copernicus Group Drew D...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Researchers & Scientists
These visionary thinkers are driving innovation around scientific breakthroughs and new technologies. Fierce Advocate. Collaborative. Uniting for Cures Shao-Lee Lin, M.D., Ph.D. Title: Executive VP, Head of Research and Development, and Chief Scientific Officer Company: Horizon Charged with build...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
2019 Red Jacket Honorees
Leaders for today and tomorrow PharmaVOICE introduced the Red Jacket Award, now in its fifth year, to celebrate the 10th anniversary of the PharmaVOICE 100. One of the criteria for being named a Red Jacket — our version of a Hall of Fame — is having been recognized previously as a PharmaVOICE 100...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Red Jacket Chris Perkin
Chris Perkin Title: CEO Company: Altasciences Industry Awards: PharmaVOICE 100, 2015, 2016, 2017, 2018; Gamechangers of the Year, 2018 Company Awards: Clinical and Research Excellence Awards (CARE), Winner, Most Successful Early Phase Research, 2019; Top 10 CRO, Pharma Tech Outlook magazine, 2019...
By Chris Perkin • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Anything But Generic Leadership Marc Kikuchi, the newly appointed CEO of Dr. Reddy’s North America — and a 2015 PharmaVOICE 100 — discusses trends in the generics industry and how he is positioning the company for success. PV: What are some of the biggest issues impacting the U.S. generics indust...
By Marc Kikuchi • June 1, 2019 -
PharmaVoice Team/PharmaVoice
The Realities of VR and AR in the Industry
Pharma brings complicated material to life with augmented and virtual reality. Imagine you are standing in your exhibit booth on a very crowded scientific and educational meeting floor, armed with fascinating, yet difficult-to-understand medical content that needs to make its way to the many pass...
By Robin Robinson • June 1, 2019 -
PharmaVoice Team/PharmaVoice
The Agile R&D Organization
A project management philosophy popular among technology companies has learnings for pharma R&D. Agile project management, first introduced in 2001, started out as a method used in software development that challenged the traditional, linear development model. The same benefits realized by th...
By Denise Myshko • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Upfront
Amgen Hosts Amgen Biotech Experience Meeting The Amgen Foundation recently hosted lab technicians who participated in the Amgen Biotech Experience (ABE). The meeting, held at Amgen’s headquarters in Thousand Oaks, Calif., allowed the lab technicians, who administer ABE to science teachers, to net...
By PharmaVoice Team • May 1, 2019 -
PharmaVoice Team/PharmaVoice
The Biosimilars Market
While the bulk of activity in the biosimilar space has taken place outside of the United States, the approval and uptake of biosimilars in the United States is expected to pick up over the next five years. The biosimilar industry has developed rapidly, and regulations have advanced significantly ...
By Denise Myshko • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The year ahead… As we come to the end of 2018, it’s important to pause and reflect on not just where we’ve been, but where we are going as an industry. In 2018, we saw continuing uncertainty in terms of the Affordable Care Act. We welcomed Alex Azar as the new Secretary of Health and Human Servic...
By Taren Grom • Nov. 15, 2018 -
PharmaVoice Team/PharmaVoice
Nontraditional Pharma Companies
As for-profit life-sciences companies abandon medicines that do not add to the corporate bottom line, nonprofit and nontraditional organizations are pursuing these promising treatments to provide patient populations with important medicines, vaccines, and generics. One such nonprofit company that...
By Robin Robinson • Oct. 1, 2018 -
PharmaVoice Team/PharmaVoice
Upping the Ante in the Fight Against Cancer
The battle to address one of the most deadly and pervasive sets of diseases has been making significant strides. While cancer — as a group of diseases — remains the second-largest killer in the United States, claiming more than 600,000 lives a year, there are a growing number of therapies and tre...
By Kim Ribbink • Oct. 1, 2018 -
PharmaVoice Team/PharmaVoice
The Business of Biologics
Since the first recombinant DNA product was approved in 1982 — Humulin developed by Genentech and marketed by Lilly — biologics have brought tremendous innovation and medical benefits to patients. More than 35 years later, the biopharma industry continues to innovate as scientific and medical kno...
By Denise Myshko • Sept. 1, 2018 -
PharmaVoice Team/PharmaVoice
Who's on the List - By Category
Who’s on the List — 2018 Indexed by Category Brand champions Beth Barron CMI/Compas Eric Densmore AbelsonTaylor Vic Noble Shire Pharmaceuticals Change Agents Michel Dahan Akebia Therapeutics Jennifer De Camara Johnson & Johnson Bunny Ellerin Columbia Business School La’Wana Harris Sanofi Dr. ...
By PharmaVoice Team • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Red Jacket Dr. Sanjit Singh Lamba
Dr. Sanjit Singh Lamba For Building A Bridge Between People and Technology Title: Managing Director Company: Eisai Pharmaceuticals India Education: MBA, Kellogg’s School of Management; PhD, Gitam University; PGDMS, University of Mumbai; MPharm, Pharmaceutical Technology, Panjab University Family:...
By PharmaVoice Team • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Red Jacket Melinda Richter
Melinda Richter For Empowering the Extraordinary Title: Global Head Company: Johnson & Johnson Innovation, JLABS Education: B Commerce, University of Saskatchewan; MBA, INSEAD Family: Victor Casale, her partner, her biggest fan and inspiration Hobbies: Heli-boarding in Alaska, diving with sha...
By PharmaVoice Team • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Reading List
On the Book Shelf What are they reading? The PharmaVOICE 100 are curious and always in pursuit of continual learning to expand their knowledge and hone their leadership strategies. This is sampling of their readlng list. Download PDF
By PharmaVoice Team • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Is the industry at a fork in the road? Can an industry that has traditionally based its business model on researching, developing, and commercializing pills and other therapeutic interventions successfully pivot to adapt to a growing wave of consumer-centric wants and needs that address more than...
By Taren Grom • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Executive Perspective: A Voice for the Times
Don’t tell her she’s too intense. Don’t tell her she can’t do something because she’s a woman. And, definitely don’t tell her something won’t work because it’s never been done before. Susan Flinn Cobian’s rise to the top was earned the old-fashioned way — hard work and perseverance. Today, she wa...
By Susan Flinn Cobian • March 1, 2018 -
PharmaVoice Team/PharmaVoice
RNAi on the Verge of Therapy Breakthroughs
One of the most exciting innovations in the field of drug discovery is ribonucleic acid interference (RNAi), where researchers are making huge progress toward a new class of therapeutics. RNAi occurs naturally in living organisms to protect against viruses. Papers published in 2013 demonstrate th...
By PharmaVoice Team • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Warp Speed Ahead It’s that time of year again — time to pause, reflect, and take stock of the year that was, while gearing up for the wild ride that lies ahead. This time last year, we had just elected a new president, and today there remains quite a bit of uncertainty as to what President Trump...
By Taren Grom • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Amgen Foundation Expands the Amgen Biotech Experience The Amgen Foundation is expanding the Amgen Biotech Experience (ABE) to reach nearly 900,000 high school students by 2020. The program will launch in nine new markets: Australia, Canada, China, France, Germany, Hong Kong SAR, Italy, Netherland...
By PharmaVoice Team • Oct. 1, 2017
Previous
